Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 5, 2019 Off

Moderna to Present at Credit Suisse 28th Annual Healthcare Conference

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…

November 5, 2019 Off

Top Leader, Hall of Fame Ambassador, Izzy Matos, Rejoins Stemtech Corporation

By BusinessWire

MIRAMAR, Fla.–(BUSINESS WIRE)–Top leader, Izzy Matos, says he can’t believe he gets to ‘go home’ again! “14 years ago, I…

November 5, 2019 Off

Catalent, Inc. Reports First Quarter Fiscal 2020 Results

By BusinessWire

Q1’20 revenue of $664.7 million increased 20% as-reported, or 22% in constant currency, from Q1’19. Adjusted its operating segments to…

November 5, 2019 Off

Almirall Makes Shift to Specialty Medicine with Veeva CRM 

By BusinessWire

Spain’s leading pharmaceutical company drives seamless customer engagement across multiple stakeholders using face-to-face, email, and web PLEASANTON, Calif.–(BUSINESS WIRE)–#commercial—Veeva Systems…

November 5, 2019 Off

Goldfinch Bio to Present Oral and Poster Presentations at the American Society of Nephrology Kidney Week 2019 Annual Meeting

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment…

November 5, 2019 Off

Rocket Pharmaceuticals Announces Participation at the Barclays Gene Editing & Gene Therapy Summit

By BusinessWire

NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that Gaurav…

November 5, 2019 Off

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

By BusinessWire

BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…

November 5, 2019 Off

Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform

By BusinessWire

− Ongoing Phase 1/2a Study of CD19 CAR-NK with Pivotal Study Expected to Enroll Patients in 2021 − Potential to…

November 5, 2019 Off

Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes

By BusinessWire

NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…

November 5, 2019 Off

The World Market for Red Biotechnology – Global Industry Analysis 2017-2019 & Forecast to 2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Red Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been added…

Posts pagination

Previous 1 … 5,370 5,371 5,372 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine